Bethany A. Austin

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction

Michael E. Nassif, Sheryl L. Windsor, Fengming Tang et al. · Circulation · 2019 · 427 citations

Medicine, Cardiology, Pharmacology +17

Delayed Hyper-Enhancement Magnetic Resonance Imaging Provides Incremental Diagnostic and Prognostic Utility in Suspected Cardiac Amyloidosis

Bethany A. Austin, W.H. Wilson Tang, E. René Rodríguez et al. · JACC. Cardiovascular imaging · 2009 · 260 citations

Medicine, Cardiology, Internal Medicine +14

Comparison of Functional Status, Electrocardiographic, and Echocardiographic Parameters to Mortality in Endomyocardial-Biopsy Proven Cardiac Amyloidosis

Bethany A. Austin, Brendan Duffy, Carmela D. Tan et al. · The American Journal of Cardiology · 2009 · 67 citations

Medicine, Cardiology, Internal Medicine +14

Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials

Michael E. Nassif, Sheryl L. Windsor, Kensey Gosch et al. · Circulation Heart Failure · 2023 · 60 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth Model

Yasser Sammour, John A. Spertus, Bethany A. Austin et al. · JACC Heart Failure · 2021 · 51 citations · Full text

Medicine, Cardiology, Internal Medicine +17